Xeris Biopharma Q3 net income $11.29 million
XERS•Xeris Biopharma reported third-quarter net income of $11.29 million, product revenue of $106.267 million versus an estimate of $101.5 million, EPS of $0.06 and operating income of $16.919 million.
1. Quarterly results
Xeris Biopharma reported third-quarter product revenue of $106.267 million, compared with an IBES estimate of $101.5 million. EPS was $0.06, operating income was $16.919 million and net income was $11.29 million.
